As Conatus Pharmaceuticals (CNAT) Valuation Rose, Mpm Asset Management Boosted by $3.64 Million Its Position; Helmerich And Payne (HP) Stake Increased by Capital International Inc

May 18, 2018 - By Kurt Siggers

Helmerich & Payne, Inc. (NYSE:HP) Logo

Mpm Asset Management Llc increased its stake in Conatus Pharmaceuticals Inc. (CNAT) by 76.26% based on its latest 2017Q4 regulatory filing with the SEC. Mpm Asset Management Llc bought 909,091 shares as the company’s stock rose 13.83% while stock markets declined. The institutional investor held 2.10M shares of the major pharmaceuticals company at the end of 2017Q4, valued at $9.71 million, up from 1.19 million at the end of the previous reported quarter. Mpm Asset Management Llc who had been investing in Conatus Pharmaceuticals Inc. for a number of months, seems to be bullish on the $116.05 million market cap company. The stock increased 0.78% or $0.03 during the last trading session, reaching $3.86. About 313,149 shares traded. Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has risen 12.92% since May 18, 2017 and is uptrending. It has outperformed by 1.37% the S&P500.

Capital International Inc increased its stake in Helmerich And Payne (HP) by 30% based on its latest 2017Q4 regulatory filing with the SEC. Capital International Inc bought 4,800 shares as the company’s stock rose 3.36% while stock markets declined. The institutional investor held 20,800 shares of the energy company at the end of 2017Q4, valued at $1.35M, up from 16,000 at the end of the previous reported quarter. Capital International Inc who had been investing in Helmerich And Payne for a number of months, seems to be bullish on the $7.98 billion market cap company. The stock increased 1.76% or $1.27 during the last trading session, reaching $73.31. About 1.06 million shares traded. Helmerich & Payne, Inc. (NYSE:HP) has risen 3.63% since May 18, 2017 and is uptrending. It has underperformed by 7.92% the S&P500.

Among 7 analysts covering Conatus Pharma (NASDAQ:CNAT), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Conatus Pharma had 17 analyst reports since September 22, 2015 according to SRatingsIntel. The firm has “Buy” rating given on Wednesday, March 7 by Oppenheimer. The firm has “Buy” rating by H.C. Wainwright given on Thursday, June 29. H.C. Wainwright initiated Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) rating on Tuesday, September 22. H.C. Wainwright has “Buy” rating and $15.0 target. The firm has “Buy” rating by H.C. Wainwright given on Thursday, April 5. As per Thursday, August 3, the company rating was maintained by Stifel Nicolaus. The firm earned “Buy” rating on Thursday, May 3 by Oppenheimer. Stifel Nicolaus maintained Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) rating on Thursday, November 5. Stifel Nicolaus has “Buy” rating and $9 target. Stifel Nicolaus maintained Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) rating on Wednesday, November 9. Stifel Nicolaus has “Buy” rating and $5 target. The firm has “Buy” rating by Oppenheimer given on Thursday, March 22. The stock of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) has “Buy” rating given on Tuesday, December 20 by H.C. Wainwright.

Investors sentiment decreased to 1.1 in Q4 2017. Its down 0.73, from 1.83 in 2017Q3. It dived, as 14 investors sold CNAT shares while 17 reduced holdings. 11 funds opened positions while 23 raised stakes. 11.71 million shares or 7.58% more from 10.89 million shares in 2017Q3 were reported. California State Teachers Retirement Sys holds 0% or 41,439 shares in its portfolio. Fny Managed Accounts Ltd Com owns 800 shares. Parallax Volatility Advisers Lp stated it has 0% of its portfolio in Conatus Pharmaceuticals Inc. (NASDAQ:CNAT). Stone Ridge Asset Mgmt Limited Company owns 31,027 shares. Aqr Cap Mgmt Lc holds 0% in Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) or 734,261 shares. Tiaa Cref Investment Limited Com accumulated 216,766 shares. Jpmorgan Chase And owns 5,672 shares for 0% of their portfolio. Voya Invest Ltd holds 0% or 14,517 shares in its portfolio. Wells Fargo Mn stated it has 0% of its portfolio in Conatus Pharmaceuticals Inc. (NASDAQ:CNAT). Bnp Paribas Arbitrage Sa holds 0% or 5,619 shares. Rhumbline Advisers holds 22,520 shares. Reilly Financial owns 22,011 shares. Acadian Asset Management Limited Liability holds 815,628 shares or 0.02% of its portfolio. Northern Trust Corp invested in 0% or 285,401 shares. Legal & General Public Ltd Com invested 0% in Conatus Pharmaceuticals Inc. (NASDAQ:CNAT).

More important recent Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) news were published by: Seekingalpha.com which released: “Conatus Pharmaceuticals: Down But Certainly Not Out” on April 28, 2018, also Seekingalpha.com published article titled: “Your Daily Pharma Scoop: Conatus Data, Solid Biosciences’ SGT-001, Ultragenyx’s Crysvita Approved”, Nasdaq.com published: “Conatus Announces Completion of Enrollment in ENCORE-PH Phase 2b Clinical Trial of Emricasan in Patients with …” on April 30, 2018. More interesting news about Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) was released by: Seekingalpha.com and their article: “Novartis In Liver Diseases NASH And PBC: A Look At The Bright Side” with publication date: May 17, 2018.

Investors sentiment is 0.96 in Q4 2017. Its the same as in 2017Q3. It is the same, as 38 investors sold HP shares while 158 reduced holdings. only 65 funds opened positions while 123 raised stakes. 112.80 million shares or 0.53% more from 112.20 million shares in 2017Q3 were reported. Huntington State Bank accumulated 2,376 shares. Envestnet Asset Management holds 8,526 shares or 0% of its portfolio. Ferguson Wellman Cap Inc owns 0.21% invested in Helmerich & Payne, Inc. (NYSE:HP) for 96,380 shares. Fmr Lc has invested 0% in Helmerich & Payne, Inc. (NYSE:HP). Us Natl Bank De holds 0.04% or 209,791 shares in its portfolio. Alabama-based Andra Ap has invested 0.02% in Helmerich & Payne, Inc. (NYSE:HP). Amp Capital Limited invested in 0.01% or 30,995 shares. Tower Rech Ltd Llc (Trc) holds 0.07% or 8,502 shares. Cadence Cap Mgmt Lc has invested 0.07% in Helmerich & Payne, Inc. (NYSE:HP). Caisse De Depot Et Placement Du Quebec holds 46,096 shares or 0.01% of its portfolio. Timber Hill Lc holds 10,683 shares. 24,559 were reported by Bb&T Securities Ltd. Moreover, Dnb Asset Mngmt As has 0.01% invested in Helmerich & Payne, Inc. (NYSE:HP) for 10,445 shares. Liberty Mutual Grp Asset Mgmt holds 0.01% of its portfolio in Helmerich & Payne, Inc. (NYSE:HP) for 4,328 shares. Hsbc Holdings Public Limited Com owns 153,426 shares.

More recent Helmerich & Payne, Inc. (NYSE:HP) news were published by: Globenewswire.com which released: “Helmerich & Payne, Inc. Announces Second Quarter Results” on April 26, 2018. Also Fool.com published the news titled: “Is Helmerich & Payne Inc. (HP) a Buy?” on April 19, 2018. Seekingalpha.com‘s news article titled: “Parker Drilling Can’t Go Any Lower, So It Seems” with publication date: May 10, 2018 was also an interesting one.

Capital International Inc, which manages about $18.21B and $672.30M US Long portfolio, decreased its stake in Johnson And Johnson (NYSE:JNJ) by 6,800 shares to 14,900 shares, valued at $2.08 million in 2017Q4, according to the filing. It also reduced its holding in Ch Robinson Worldwide Inc (NASDAQ:CHRW) by 9,400 shares in the quarter, leaving it with 38,050 shares, and cut its stake in Incyte Corp (NASDAQ:INCY).

Since December 15, 2017, it had 0 buys, and 4 selling transactions for $1.42 million activity. Shares for $147,679 were sold by MARSHALL CHAPMAN PAULA. $264,718 worth of stock was sold by Stauder Robert L. on Wednesday, May 9.

Among 37 analysts covering Helmerich & Payne (NYSE:HP), 10 have Buy rating, 7 Sell and 20 Hold. Therefore 27% are positive. Helmerich & Payne had 136 analyst reports since August 3, 2015 according to SRatingsIntel. iBERIA Capital Partners maintained Helmerich & Payne, Inc. (NYSE:HP) rating on Monday, April 4. iBERIA Capital Partners has “Sector Perform” rating and $61 target. Scotia Capital maintained it with “Hold” rating and $82 target in Thursday, March 23 report. The firm earned “Sell” rating on Monday, February 12 by Seaport Global. The rating was maintained by Stifel Nicolaus with “Hold” on Monday, May 29. On Thursday, December 21 the stock rating was upgraded by Tudor Pickering to “Buy”. The firm earned “Buy” rating on Thursday, August 27 by TheStreet. The stock has “Hold” rating by Cowen & Co on Thursday, August 10. RBC Capital Markets maintained Helmerich & Payne, Inc. (NYSE:HP) on Friday, June 30 with “Hold” rating. The rating was maintained by Susquehanna on Wednesday, March 9 with “Neutral”. On Thursday, July 20 the stock rating was maintained by RBC Capital Markets with “Hold”.

Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts